New York, NY, United States of America

Eileen A Friedman


Average Co-Inventor Count = 3.3

ph-index = 2

Forward Citations = 77(Granted Patents)


Company Filing History:


Years Active: 1986-1988

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Eileen A. Friedman: Innovator in Cancer Research

Introduction

Eileen A. Friedman is a prominent inventor based in New York, NY, known for her significant contributions to cancer research. With a focus on innovative methods for diagnosing and treating gastrointestinal cancers, she has made strides in the field of medical science. Eileen holds 2 patents that reflect her dedication to advancing cancer research and improving patient outcomes.

Latest Patents

Eileen's latest patents include a method for the growth in tissue culture of normal colonic epithelial cells. This invention concerns a method for the routine primary culture of human colonic epithelial cells within a monolayer. The research demonstrated that 12-0-tetradecanoylphorbol-13-acetate (TPA) enhanced DNA synthesis an average of eight-fold when assayed by [.sup.3 h]dThd labeling indices in colonic epithelial cells from familial polyposis patients and in tubular adenomas. Notably, no such stimulation by TPA was observed in cells from high-risk patients without familial polyposis or in cells from low-risk subjects. Another significant patent involves a panel of monoclonal antibodies produced from human gastrointestinal tumors, which serves as a diagnostic probe for colon cancer. This antibody panel subsets the human gastrointestinal tract in its reactivity vis-a-vis the esophagus, stomach, small intestine, and colon.

Career Highlights

Eileen A. Friedman is affiliated with the Sloan-Kettering Institute for Cancer Research, where she continues her impactful work in cancer research. Her innovative approaches have contributed to the understanding and diagnosis of gastrointestinal cancers, making her a valuable asset in the medical community.

Collaborations

Eileen has collaborated with notable colleagues, including Junichi Sakamoto and Carlos Cordon-Cardo, further enhancing her research efforts and expanding the impact of her work.

Conclusion

Eileen A. Friedman exemplifies the spirit of innovation in cancer research through her patents and contributions to the field. Her work not only advances scientific knowledge but also holds the potential to improve diagnostic methods for gastrointestinal cancers.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…